v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 335 $ 689
Restricted cash and cash equivalents (Note 16) 14 63
Accounts receivable (Note 3) 304 196
Inventory, net (Note 5) 316 278
Derivative instruments (Notes 2 and 11) 122 56
Other current assets 61 67
Total current assets 1,152 1,349
Property, plant and equipment, net (Note 7) 11,858 7,546
Nuclear decommissioning trust funds (Notes 6 and 11) 1,976 1,900
Derivative instruments (Notes 2 and 11) 9 4
Other noncurrent assets 92 106
Total Assets 15,087 10,905
Liabilities and Equity    
Long-term debt, due within one year (Notes 10 and 11) 29 29
Accrued interest 169 60
Accounts payable and other accrued liabilities 391 281
Derivative instruments (Notes 2 and 11) 617 101
Stock-based compensation liabilities (Note 13) 2 501
Other current liabilities 82 78
Total current liabilities 1,290 1,050
Long-term debt (Notes 10 and 11) 9,540 6,782
Derivative instruments (Notes 2 and 11) 243 67
Postretirement benefit obligations (Note 12) 203 229
Asset retirement obligations and accrued environmental costs (Note 8) 500 494
Deferred income taxes 938 486
Acquired contract liabilities (Note 17) 734 662
Other noncurrent liabilities 36 42
Total Liabilities 13,484 9,812
Commitments and Contingencies (Note 9)
Stockholders' Equity (Note 15)    
Common stock ($0.001 par value, 350,000,000 shares authorized) [1] 0 0
Additional paid-in capital 2,562 1,709
Accumulated retained earnings (deficit) (947) (612)
Accumulated other comprehensive income (loss) (35) (4)
Total Stockholders' Equity 1,580 1,093
Noncontrolling interests 23 0
Total Equity 1,603 1,093
Total Liabilities and Stockholders' Equity $ 15,087 $ 10,905
[1]
(a)47,316,772 and 45,687,828 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively.